- 全部删除
您的购物车当前为空
Mifamurtide sodium is a drug against osteosarcoma, a kind of bone cancer mainly affecting children and young adults. It was approved in Europe in March 2009.

Mifamurtide sodium is a drug against osteosarcoma, a kind of bone cancer mainly affecting children and young adults. It was approved in Europe in March 2009.
| 规格 | 价格 | 库存 | 数量 |
|---|---|---|---|
| 100 mg | 待询 | 待询 | |
| 500 mg | 待询 | 待询 |
Mifamurtide sodium 相关产品
| 产品描述 | Mifamurtide sodium is a drug against osteosarcoma, a kind of bone cancer mainly affecting children and young adults. It was approved in Europe in March 2009. |
| 别名 | 米伐木肽钠盐, Muramyl tripeptide, Mepact, L-MTP-PE, Junovan, CGP 19835A |
| 分子量 | 1259.48 |
| 分子式 | C59H108N6NaO19P |
| CAS No. | 90825-43-7 |
| 密度 | no data available |
| 存储 | keep away from moisture | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
评论内容